Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
暂无分享,去创建一个
M. Pfeffer | A. Levey | N. Bansal | Jianwen Cai | J. Kusek | Chi-yuan Hsu | D. Weiner | L. Hunsicker | Kathleen D. Liu | M. Carpenter | M. Bennett | Meyeon Park | C. Hsu | Kathleen D. Liu
[1] A. Go,et al. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2015, American Journal of Kidney Diseases.
[2] S. Kritchevsky,et al. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] A. Newman,et al. Association of urinary injury biomarkers with mortality and cardiovascular events. , 2014, Journal of the American Society of Nephrology : JASN.
[4] K. Anastos,et al. Urinary biomarkers of kidney injury are associated with all‐cause mortality in the Women's Interagency HIV Study (WIHS) , 2014, HIV medicine.
[5] M. Bottai,et al. Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[6] R. Vasan,et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus , 2014, Diabetologia.
[7] R. Vasan,et al. Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. , 2013, Journal of the American Society of Nephrology : JASN.
[8] C. Forsblom,et al. Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes , 2013, Diabetes Care.
[9] Svetlana K. Eden,et al. Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function , 2013, Kidney international.
[10] T. Uzu,et al. Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy , 2013, Diabetes Care.
[11] M. Shlipak,et al. Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. , 2013, Journal of the American Society of Nephrology : JASN.
[12] E. Ingelsson,et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. , 2013, Atherosclerosis.
[13] H. Feldman,et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease , 2013, Kidney international.
[14] Chiao-Yin Sun,et al. Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients , 2013, PloS one.
[15] J. Ishii,et al. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease , 2013, Heart and Vessels.
[16] H. Arima,et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease ( CKD ) , 2013 .
[17] Mardge H. Cohen,et al. Urinary Markers of Kidney Injury and Kidney Function Decline in HIV-Infected Women , 2012, Journal of acquired immune deficiency syndromes.
[18] B. Astor,et al. Age and association of kidney measures with mortality and end-stage renal disease. , 2012, JAMA.
[19] D. Siscovick,et al. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] J. Dear,et al. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. , 2012, Kidney international.
[21] B. Kasiske,et al. Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] P. Reese,et al. Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[23] A. Köttgen,et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] M. Kim,et al. Serum Neutrophil Gelatinase‐Associated Lipocalin and Interleukin‐18 as Predictive Biomarkers for Delayed Graft Function After Kidney Transplantation , 2012, Journal of clinical laboratory analysis.
[25] H. Parving,et al. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. , 2012, Diabetes research and clinical practice.
[26] Catherine D Krawczeski,et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. , 2011, Journal of the American Society of Nephrology : JASN.
[27] H. Parving,et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. , 2011, Kidney international.
[28] G. Navis,et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] S. Solomon,et al. Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial , 2011, Circulation.
[30] S. Tatsunami,et al. Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients , 2011, Diabetes Care.
[31] Shi-Xian Deng,et al. The Ngal Reporter Mouse Detects the Response of the Kidney to Injury in Real Time , 2010, Nature Medicine.
[32] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[33] K. Salmela,et al. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. , 2011, Kidney international.
[34] H. Parving,et al. Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-Up Study , 2010, Nephron Clinical Practice.
[35] V. Jeevanandam,et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. , 2010, American Society of Nephrology. Clinical Journal.
[36] Gang Wang,et al. Urinary expression of kidney injury markers in renal transplant recipients. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[37] E. Siew,et al. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[38] H. Parving,et al. Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients , 2010, Diabetes Care.
[39] C. Parikh,et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[40] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[41] H. Lee,et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[42] D. Bolignano,et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[43] S. Chaturvedi,et al. Assay Validation for KIM-1: human urinary renal dysfunction biomarker , 2009, International journal of biological sciences.
[44] M. Pfeffer,et al. Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] Joseph V Bonventre,et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. , 2008, The Journal of clinical investigation.
[46] F. Grenier,et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[47] K. Mori,et al. Dual action of neutrophil gelatinase-associated lipocalin. , 2007, Journal of the American Society of Nephrology : JASN.
[48] T. Sugaya,et al. Urinary fatty acid binding protein in renal disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[49] M. Pfeffer,et al. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. , 2006, American heart journal.
[50] A. Djamali,et al. Medical care of kidney transplant recipients after the first posttransplant year. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[51] Q. Mac,et al. Urine NGAL and IL-18 are Predictive Biomarkers for Delayed Graft Function Following Kidney Transplantation , 2006 .
[52] H. R. Payne,et al. Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene. , 2005, American journal of physiology. Cell physiology.
[53] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[54] J. Gracie. Interleukin‐18 as a potential target in inflammatory arthritis , 2004, Clinical and experimental immunology.
[55] A. McIntosh,et al. Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells. , 2004, Biochemistry.
[56] B. Atshaves,et al. Decreased Liver Fatty Acid Binding Capacity and Altered Liver Lipid Distribution in Mice Lacking the Liver Fatty Acid-binding Protein Gene* , 2003, Journal of Biological Chemistry.
[57] J. Bonventre,et al. Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration* , 2002, The Journal of Biological Chemistry.
[58] M. Lucia,et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. , 2001, The Journal of clinical investigation.
[59] W E Barlow,et al. Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.
[60] J. Cowland,et al. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.
[61] W. Barlow,et al. Robust variance estimation for the case-cohort design. , 1994, Biometrics.